About this event
Presentation - “Evolving Strategic Context for Phages, Opening New Opportunities” with :
- Thibaut du Fayet, PHAXIAM CEO
- Dr. Pascal Birman, PHAXIAM CMO
Round Table – “Critical Needs for Individualized Phages Treatments in Europe” with :
- Dr. Robert Sebbag (MD, Infectiologist, La Pitié-Salpétrière – Paris)
- Dr. Antonia Scobie (MD, Infectiologist, Royal Free London NHS Foundation Trust – London)
- Prof. Volker Alt (MD, Director and Chairman of Department of Trauma Surgery University Medical Centre Regensburg)
- Dr. Truong-Thanh PHAM (MD, Infectiologist, Hôpitaux Universitaires de Genève – Genève)
Q&A Session
Hosted by
-
Guest speaker
Dr. Truong-Thanh Pham MD, Infectiologist, Hôpitaux Universitaires de GenèveG
-
Guest speaker
Prof. Volker Alt MD, Director and Chairman of Department of Trauma Surgery University Medical Centre RegensburgG
-
Guest speaker
Jérôme Bailly Chief Quality Officer, Deputy General Manager and Qualified Person @ PhaxiamG
-
Guest speaker
Dr. Robert Sebbag MD, Infectiologist, La Pitié-Salpétrière – ParisG
-
Guest speaker
Dr. Antonia Scobie MD, Infectiologist, Royal Free London NHS Foundation Trust – LondonG
-
Guest speaker
Thibaut du Fayet CEO @ PhaxiamG
-
Guest speaker
Dr. Pascal Birman CMO @ PhaxiamG
Direct Dirigeants by NewCap
La plateforme d’échanges avec les dirigeants de sociétés cotées en bourseNewCap a conçu une plateforme d’événements sur mesure pour créer, enrichir et pérenniser la relation entre les sociétés cotées et leurs actionnaires.
